ClinicalTrials.Veeva

Menu

Evaluation of PICOLIGHT Plus COOLPREP, PICOLIGHT Plus CLICOLON for Bowel Preparation

N

National Cancer Center (NCC)

Status and phase

Completed
Phase 2

Conditions

Healthy

Treatments

Drug: Picolight + Clicolon
Drug: Picolight + Coolprep

Study type

Interventional

Funder types

Other

Identifiers

NCT01919255
NCC-CAN-001

Details and patient eligibility

About

The purpose of this study to bowel cleansing evaluation of mixed two other type bowel preparation drug(PICOLIGHT plus COOLPREP, PICOLIGHT plus CLICOLON).

Full description

To evaluate mixed-drug bowel preparation methods for decreasing side effect and increasing compliance

Picolight + Coolprep [Day-Prior] Picolight + Clicolon [Day-Prior] Picolight + Coolprep [Split-Dose] Picolight + Clicolon [Split-Dose]

Enrollment

236 patients

Sex

All

Ages

20 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 20-65 years of age
  • Elective colonoscopy of outpatients(consent to the study)

Exclusion criteria

  • Active enteritis, enteric bleeding, obstruction
  • Pregnant or lactating women
  • Severe liver or renal insufficiency
  • Allergic to any preparation components
  • History of heart disease (ischemic heart disease, congestive heart failure, arrythmia)
  • History of colorectal surgery
  • History abdominal surgery within 6 month
  • Toxic colitis or megacolon
  • Nausea or vomiting
  • Status emergent abdominal surgery (ex. acute appendicitis)
  • Uncontrolled clinically significant pre-existing electrolyte disturbance
  • Dehydration
  • Phenylketonuria
  • Glucose-6-phosphate dehydrogenase deficiency
  • Ileus
  • Suspicious hyperphosphatemia
  • Acute phosphate nephropathy

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

236 participants in 4 patient groups

Picolight + Coolprep (Day-Prior)
Active Comparator group
Description:
Picolight (1p/250cc, 5PM) + Coolprep (500cc x 2, 8PM)\[Day-Prior\]
Treatment:
Drug: Picolight + Coolprep
Picolight + Clicolon (Day-Prior)
Active Comparator group
Description:
Picolight (1p/250cc, 5PM) + Clicolon (4T x 4, 8PM) \[Day-Prior\]
Treatment:
Drug: Picolight + Clicolon
Picolight + Coolprep (Split-Dose)
Active Comparator group
Description:
Picolight (1p/250cc, 7PM) + Coolprep (500cc x 2, 5AM)\[Split-Dose\]
Treatment:
Drug: Picolight + Coolprep
Picolight + Clicolon (Split-Dose)
Active Comparator group
Description:
Picolight (1p/250cc, 7PM) + Clicolon (4T x 4, 5AM)\[Split-Dose\]
Treatment:
Drug: Picolight + Clicolon

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems